RIOTER-PLUS
Ofloxacin 0.75%w/w,Ornidazole 2%w/w,Itraconazole 1%w/w & Clobetasol 0.05%w/w Cream
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | RIOTER-PLUS |
| Active Formulation (Salt) | Ofloxacin 0.75%w/w,Ornidazole 2%w/w,Itraconazole 1%w/w & Clobetasol 0.05%w/w Cream |
| Dosage Form | DERMA |
| Packaging Presentation | 15gm |
| Therapeutic Category | DERMA |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is RIOTER-PLUS?
Therapeutic monograph and clinical profile
RIOTER-PLUS (Ofloxacin 0.75%w/w,Ornidazole 2%w/w,Itraconazole 1%w/w & Clobetasol 0.05%w/w Cream) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 15gm, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Mixed or Unidentified Skin Infections /Infected Chronic Sweat Rashes & Intertrigo.
Key Formulation Highlights
Why healthcare professionals recommend RIOTER-PLUS
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Mixed or Unidentified Skin Infections /Infected Chronic Sweat Rashes & Intertrigo
Pharmacological Mechanism of Action
How RIOTER-PLUS acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for RIOTER-PLUS
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for RIOTER-PLUS across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding RIOTER-PLUS
What is RIOTER-PLUS used for?
What is the active composition of RIOTER-PLUS?
How can I get monopoly PCD franchise for RIOTER-PLUS in my district?
What is the packaging and MRP of RIOTER-PLUS?
Related Formulations in DERMA
Explore complementary WHO-GMP certified healthcare formulations
